Dementia Discovery
Venture capitalLondon · Pre-Seed–Series C · 6 people tracked
Also known as Dementia Discovery Fund
Investment thesis
DDF backs bold entrepreneurs across the full spectrum of company and asset stages within dementia therapeutics, and creates new biotech companies itself where none exist. Its mandate is to interrogate novel hypotheses and expand the breadth of targets and mechanisms for dementia therapies, investing in early-stage projects from target identification onward to translate novel biology into disease-modifying drugs. Covering Alzheimer's and other dementias such as PDD, FTD, ALS and HD, the fund pursues a dual mandate of delivering measurable patient impact and generating strong financial returns, drawing on a network of venture partners, entrepreneurs, scientists and strategic pharmaceutical partners.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from public directories
What they invest in
from 2 of 4 portfolio companiesBiotech ×2Healthtech ×2Deep Tech ×1Medical Devices ×1
HQs:United States×2
Investments · 4 tracked
founders shown can be your intro pathCambridge, US
Board seatJonathan Behr· per SEC Form D
Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS.
BiotechDeep TechHealthtech
Craig Thompson(Chief Executive Officer)Sagar Vaidya(Chief Medical Officer)Carrie Ann Cook(Chief Business Officer)
SV Health Investors is a global private equity and venture capital investment platform specializing in healthcare across biotechnology, medical devices, and healthcare growth equity.
BiotechHealthtechMedical DevicesBoston, US
Frequently asked questions
- What stage does Dementia Discovery invest at?
- Dementia Discovery invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.
- What sectors does Dementia Discovery focus on?
- Dementia Discovery focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is Dementia Discovery located?
- Dementia Discovery is headquartered in London, GB.
- Does Dementia Discovery lead rounds?
- Dementia Discovery typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the team
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Tenmile is an Australia-based venture firm investing in health and life sciences companies from seed stage onward, aiming to connect Australian innovation to global markets.
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Equitage Ventures invests in early-stage companies addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.